A phase 2 study of ofirnoflast showed 67% overall hematologic improvement and 55% transfusion independence in ESA-refractory lower-risk MDS.

Myelodysplastic syndromes (MDS) are cancers that make too few working blood cells, which can cause weakness, shortness of breath, bruising, and frequent infections. A balanced, high-energy eating plan ...

Myelodysplastic syndromes (MDS) often require frequent blood transfusions for anemia, which can lead to iron overload. Over time, extra iron can damage organs throughout the body. Underlying MDS ...

Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Authors acknowledge that both the 2022 World Health Organization and International Consensus Classification myelodysplastic syndrome criteria sets have value, while sorting out their similarities and ...

MCC is expected to release the NEET Master of Dental Surgery Counselling process soon. Candidates who have qualified should ...